Showing results (271-280 of 1,019) with videos related to
Sort By:
Pageof 102
Journal of Pharmaceutical Policy and Practice|November 7, 2025
Factors influencing rational antibiotic use behaviours of early childhood caregivers in three tertiary care hospitals, Bangkok metropolitan: a cross-sectional descriptive studySupreeda Manipantee, Jintana KasemsiriJournal of Pharmaceutical Policy and Practice|September 26, 2025
Drug shortages: clinical implications and burdens - a trinational multiple-methods study including key stakeholdersOlaf Rose, Kreshnik Hoti, Blete Isufi, et al.Journal of Pharmaceutical Policy and Practice|September 29, 2025
Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023Khairul Anuar Abdul Karim, Asyraf Elmiza Ahmad, Mohd Zawawi Abdullah, et al.Journal of Pharmaceutical Policy and Practice|May 27, 2024
A cost-effectiveness analysis for high versus standard (low) dose caffeine for the treatment of apnea in neonatal intensive care unitEilan Al-Hersh, Dina Abushanab, Fouad AbouNahia, et al.Journal of Pharmaceutical Policy and Practice|December 9, 2022
A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines listIan Naicker, Fatima Suleman, Velisha Ann Perumal-PillayJournal of Pharmaceutical Policy and Practice|October 12, 2020
How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysisColin Whaley, Ashley Bancsi, Joanne Man-Wai Ho, et al.Journal of Pharmaceutical Policy and Practice|October 12, 2020
An antibiotic stewardship program in a surgical ICU of a resource-limited country: financial impact with improved clinical outcomesKashif Hussain, Muhammad Faisal Khan, Gul Ambreen, et al.Journal of Pharmaceutical Policy and Practice|June 13, 2022
Drug shortages in low- and middle-income countries: Colombia as a case studyMartha L Sabogal De La Pava, Emily L TuckerJournal of Pharmaceutical Policy and Practice|June 1, 2021
Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)Rumiko Shimazawa, Masayuki IkedaJournal of Pharmaceutical Policy and Practice|January 5, 2021
Repurposing existing drugs for new uses: a cohort study of the frequency of FDA-granted new indication exclusivities since 1997Babak Sahragardjoonegani, Reed F Beall, Aaron S Kesselheim, et al.Pageof 102